Get started
Author

Maria Antonietta Di Rosolini

Observed names: M.A. DI Rosolini, M.A. Di Rosolini, Maria Antonietta di Rosolini, Maria Di Rosolini
ORCID: 0000-0003-4905-5072
Observed ORCID: 0000-0003-4905-5072
OpenAlex ID: A5077477557
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents
2018 · Vincenza Calvaruso, Giuseppe Cabibbo, et al. · Gastroenterology · 380
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients
2019 · Giuseppe Cabibbo, Ciro Celsa, et al. · Journal of Hepatology · 212
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
2020 · Francesco Perrone, Maria Carmela Piccirillo, et al. · Journal of Translational Medicine · 144
PDF
Clinical characteristics and predictors of death among hospitalized patients infected with SARS‑CoV‑2 in Sicily, Italy: A retrospective observational study
2022 · Federica Cosentino, Vittoria Moscatt, et al. · Biomedical Reports · 26
PDF
Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST‐HCV cohort
2021 · Vincenza Calvaruso, Salvatore Petta, et al. · Journal of Viral Hepatitis · 26
PDF
Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients
2019 · G. Cabibbo, C. Celsa, et al. · Digestive and Liver Disease · 15
Disease outcomes after DAA-induced SVR: data from the resist-HCV cohort
2018 · V. Calvaruso, S. Petta, et al. · Journal of Hepatology · 6
Factors Enhancing Treatment of Hepatitis C Virus–Infected Italian People Who Use Drugs: The CLEO-GRECAS Experience
2021 · Luca Rinaldi, Vincenzo Messina, et al. · The American Journal of Gastroenterology · 5
Dyspnea and fatigue in Long-COVID: definition of risk factors and of DLCO-based phenotypes in a multicenter study of 765 patients from Italy
2026 · Marco Floridia, Liliana Elena Weimer, et al. · Respiratory Medicine · 2
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
2021 · Francesco Perrone, Maria Carmela Piccirillo, et al. · Journal of Translational Medicine · 1
PDF
THU-166-Treatment of 320 genotype 3 cirrhotic patients with 12 weeks of sofosbuvir/velpatasvir with or without ribavirin: Real life experience from Italy
2019 · Luisa Pasulo, Martina Gambato, et al. · Journal of Hepatology · 1
Treatment of 320 genotype 3 cirrhotic patients with 12 weeks Sofosbuvir/Velpatasvir with or without ribavirin: real life experience from Italy
2019 · L. Pasulo, M. Gambato, et al. · Digestive and Liver Disease · 1
New Cardiovascular Diagnoses, Symptoms and Functional Status Following SARS-CoV-2 Infection in a National Cohort of 1,734 Patients in Italy
2026 · Marco Floridia, Gianfranco Parati, et al. · Heart Lung and Circulation
Factors affecting exercise performance at the 6-min walk test in long-COVID: a multicenter study from Italy
2026 · Marco Floridia, Liliana Elena Weimer, et al. · Internal and Emergency Medicine
Administration of antivirals, IL-6 inhibitors, monoclonal neutralizing antibodies and systemic corticosteroids in acute SARS-CoV-2 infection do not reduce the subsequent burden of Long-COVID symptoms
2025 · Marco Floridia, Liliana Elena Weimer, et al. · Infezioni in Medicina
PDF
P-556. Efficacy and Safety of Bictegravir/Emtricitabine/TenofovirAlafenamide in Females Living With HIV: 96 Weeks Real Life Analysis
2025 · Andrea De Vito, Manuela Ceccarelli, et al. · Open Forum Infectious Diseases
PDF
Efficacy and safety of pangenotypic DAAs for chronic HCV infection: real-world data from the RESIST-HCV cohort
2022 · F. Salomone, I. Cacciola, et al. · Digestive and Liver Disease
Effectiveness of new generation DAAs for HCV infection in a large cohort of Italian people who use drugs (PWID): the cleo-grecas real-world experience
2020 · Vincenzo Messina, Vincenzo Iovinella, et al. · Journal of Hepatology
Second-generation DAAs for HCV: real-life efficacy in the resist-HCV cohort
2020 · Irene Cacciola, Salvatore Petta, et al. · Journal of Hepatology
Second-generation DAAs for HCV: real-life efficacy in the RESIST-HCV cohort
2019 · I. Cacciola, S. Petta, et al. · Digestive and Liver Disease
Oc.07.1 Direct Acting Antivirals After Successful Treatment of Early Hepatocellular Carcinoma Improve Survival and Reduce Hepatic Decompensation in Hcv-cirrhotic Patients
2019 · C. Celsa, G. Cabibbo, et al. · Digestive and Liver Disease
Works count: 22
Citation count: 1,199
H-index: 7
I10-index: 7
Year
Topic
Type